FOX CHASE CANCER CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-05-06
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00039520
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
Phase 2
Withdrawn
- Conditions
- Kidney Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-11
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT00025519
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT00039507
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath